MarvelBiome, Inc. is a clinical-stage biopharmaceutical company headquartered in Woburn, Massachusetts, focused on harnessing the power of microbes to treat human diseases.
Subscribe to see MarvelBiome, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
MarvelBiome, Inc. is a company headquartered in United States. It has raised at least $54.9M across the 4 funding rounds on record. Its most recent funding round raised $39.6M in October 2025. Xcout tracks 18 named people at MarvelBiome, Inc., including J. Amaranath Govindan (President).
12 more named people on record for MarvelBiome, Inc., with roles, board committees and tenure — see the full roster →
At least $54.9M raised across the 4 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $39.6M | — | |
| SEC Form D filing | $10M | — | |
| SEC Form D filing | $3.1M | — | |
| SEC Form D filing | $2.3M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of MarvelBiome, Inc.'s closest competitors — see the full list of competitors and alternatives →
Holobiome, Inc. is a biotechnology company founded in 2015 and headquartered in Boston, Massachusetts. The company focuses on discovering and developing novel therapeutics targeting the human microbiome to treat various disorders.
Evelo Biosciences, Inc. is a clinical-stage biotechnology company founded in 2015 and headquartered in Cambridge, Massachusetts. The company focuses on developing a novel class of orally delivered therapeutics that act on the small intestinal axis to treat inflammatory diseases.
DeepBiome Therapeutics, Inc. is a venture-backed startup company headquartered in Cambridge, Massachusetts, focused on therapeutics.
Vedanta Biosciences, Inc. is headquartered in Cambridge, Massachusetts, and develops groundbreaking microbiome-derived immunotherapies and therapeutics to improve patient lives.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.